Why Elevance Health, Inc. (ELV) Stock Rose 1.1% on Nov 20, 2026
as of Friday, 2:33 PM ET
The reason we found
Analyst Upgrade and ETF Buying Support Elevance Shares
Elevance was listed among stocks analysts upgraded, while the Avantis U.S. Large Cap Value ETF reportedly made Elevance its largest purchase on November 18. Those positive signals could plausibly have improved sentiment and contributed to the stock’s 2.65% rise, although the articles do not identify a single decisive catalyst.
analyst upgrade and fund buyingmedium confidence
Sources 6
- Elevance Health (ELV) Down 12.4% Since Last Earnings Report: Can It Rebound?finnhub.io
- Can UnitedHealth Group Stock Rally 50% After This Dip?finnhub.io
- What Avantis U.S. Large Cap Value ETF (AVLV) Bought: Elevance Leads on Nov. 18finnhub.io
- What Argus Sees in Elevance Health (ELV) for 2027finnhub.io
- UnitedHealth Stock Slips: What's Going On?finnhub.io
- What Just Happened To UnitedHealth Stock?finnhub.io
Our call
Keepdated Sep 21, 2026
Elevance Health fell 8.1% over the past five trading days, in step with other health care stocks (down 6.3%), even though its report on Oct 21 beat profit forecasts by 50%. Elevance Health's next report could raise the call with a profit beat, or lower it with a miss.
Other moves on Nov 20
- IREN−18.0%Funding gap and AI-sector pressure send IREN sharply lower
- AAOI−16.6%AAOI tumbles as tech pullback meets potential share dilution
- SNDK−16.0%Bearish NAND pricing outlook sends SanDisk shares sharply lower
- CRDO−15.2%Stifel Cuts Credo Price Target Despite Maintaining Buy Rating
- SMTC−14.3%Semtech Stock Drops After Analyst Lowers Price Target
- XPEV−13.9%HSBC Downgrade Sends XPeng Shares Sharply Lower